Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Large liver cell dysplasia: a controversial entity.

Young Nyun Park1, Massimo Roncalli

  • 1Department of Pathology, Center for Chronic Metabolic Disease, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.

Journal of Hepatology
|September 20, 2006
PubMed
Summary

Large cell change (LCC) in cirrhosis is a debated liver lesion. Research highlights its heterogeneity and the need for molecular insights to understand its reactive or preneoplastic nature.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ginsenoside Rh<sub>3</sub> enhances regorafenib efficacy in hepatocellular carcinoma by modulating FGFR4-STAT3-YAP signaling pathway.

Biochemical pharmacology·2026
Same author

Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer.

Clinical and molecular hepatology·2025
Same author

Vessels That Encapsulate Tumor Cluster+ Unresectable Hepatocellular Carcinomas Benefit of Antiangiogenic Therapy.

Liver cancer·2025
Same author

Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trials.

Journal of hepatology·2025
Same author

The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment.

Lancet (London, England)·2025
Same author

Notoginsenoside Ft1 induces lysosomal cell death and apoptosis by inhibiting the PI3K/AKT/mTOR pathway in hepatocellular carcinoma.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025

Area of Science:

  • Hepatology
  • Gastroenterology
  • Cellular Pathology

Background:

  • Large cell change (LCC) is a term for liver cell dysplasia, often found in cirrhosis.
  • The premalignant potential of LCC remains uncertain due to insufficient evidence.
  • The origin, natural history, and fate of LCC are subjects of ongoing scientific debate.

Purpose of the Study:

  • To critically evaluate existing research on the nature of large cell change (LCC).
  • To emphasize the importance of LCC heterogeneity in understanding liver cell biology.
  • To explore the dysplastic versus reactive nature of LCC lesions.

Main Methods:

  • Review of morphologic, phenotypic, molecular, and clinical studies.
  • Comparative analysis with experimental liver carcinogenesis models.

Related Experiment Videos

  • Discussion of the limitations of morphology and the value of intracellular analysis.

    • Main Results:

    • LCC is a well-defined microscopic lesion, frequently associated with cirrhosis.
    • Morphologic similarities exist between LCC and lesions in experimental liver carcinogenesis.
    • No direct human tissue counterparts are known for LCC's uncertain reactive or preneoplastic status.

    Conclusions:

    • The heterogeneity of LCC is a critical factor for biological understanding.
    • Further molecular and intracellular investigations are necessary to resolve the LCC debate.
    • LCC serves as a model for understanding the limits of morphology in diagnosing dysplasia.